Literature DB >> 9570207

ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation).

G Gregoratos, M D Cheitlin, A Conill, A E Epstein, C Fellows, T B Ferguson, R A Freedman, M A Hlatky, G V Naccarelli, S Saksena, R C Schlant, M J Silka.   

Abstract

Mesh:

Year:  1998        PMID: 9570207     DOI: 10.1161/01.cir.97.13.1325

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  30 in total

1.  Determining the optimal pacing intervention rate for vasovagal syncope.

Authors:  A S Kurbaan; A C Franzén; Z Stack; D Heaven; G Mathur; R Sutton
Journal:  J Interv Card Electrophysiol       Date:  2000-12       Impact factor: 1.900

Review 2.  Neurally mediated syncope.

Authors:  M Zaqqa; A Massumi
Journal:  Tex Heart Inst J       Date:  2000

Review 3.  Implantable dual-chamber cardioverter-defibrillator-pacemaker.

Authors:  D Pfeiffer; M Mende; A Hagendorff
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931

4.  Symptomatic Ventricular Tachycardia.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-08

Review 5.  Neurocardiogenic syncope.

Authors:  Carol Chen-Scarabelli; Tiziano M Scarabelli
Journal:  BMJ       Date:  2004-08-07

6.  Surviving ventricular standstill for 111 seconds during Holter monitoring.

Authors:  Maninder Sidhu; H P Singh; Arun K Chopra; Deepak Kapila; Shailpreet Sidhu
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-01       Impact factor: 1.468

7.  Use of "IEGM Online" in ICD patients--early detection of inappropriate classified ventricular tachycardia via home monitoring.

Authors:  Oliver Ritter; Wolfgang R Bauer
Journal:  Clin Res Cardiol       Date:  2006-06-20       Impact factor: 5.460

8.  Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation.

Authors:  Anders Agård; Rurik Löfmark; Nils Edvardsson; Inger Ekman
Journal:  J Med Ethics       Date:  2007-09       Impact factor: 2.903

Review 9.  Syncope: investigation and treatment.

Authors:  Satish R Raj; Robert S Sheldon
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

Review 10.  Should all implantable cardioverter defibrillators for ventricular arrhythmias be dual-chamber devices?

Authors:  K L Lee; C P Lau
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.